Advertisement

Sleep pp 71-82 | Cite as

Melatonin and sleep-wake rhythm

  • B. Claustrat

Abstract

Melatonin is the main hormone secreted by the pineal gland. This is not a recently discovered substance, having been identified in 1958 by Lerner et al. [44], and synthesised in the following year. It is a lipophilic compound with an indole structure derived from serotonin using a two-step biochemical process. The role of melatonin, a hormone secreted during the night, is to inform the brain of the alternating periods of day and night, so that the organism is in phase with the light environment. The hormonal message adjusts to variations in the duration of night (scotophase) in the course of the year. Thus in seasonally reproducing animals, modifications in melatonin secretion will prompt mating and the subsequent birth of the litter, at a favourable period of the year. Generally speaking, melatonin participates in regulating rhythmic phenomena, whether daily or annually. The physiological role of melatonin in man is only partially understood and certain data are open to question. Indeed, due to its lack of any known short term toxicity, the substance has been subject to a multitude of studies which are either uncontrolled or involve doses generating blood concentrations far higher than physiological concentrations.

Keywords

Cluster Headache Circadian Clock Pineal Gland Phase Advance Melatonin Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    ANTON-TAY F., DIAZ J.L., FERNANDEZ-GUARDIOLA M. - On the effects of melatonin upon human brain: its possible therapeutic implication.Life Sci., 10, 841–850, 1971.CrossRefGoogle Scholar
  2. 2.
    AKERSTEDT T., FRÖBERG J.E., FRIBERG Y., WETTERBERG L. - Melatonin excretion, body temperature and subjective arousal during 64-hours of sleep deprivation. Psychoneuroendocrinology, 4, 219–225, 1979.PubMedCrossRefGoogle Scholar
  3. 3.
    ARENDT J., ALDHOUS M., MARKS V. - Alleviation of jet lag by melatonin: preliminary results of controlled double blind trial. BMJ, 292, 1170, 1986.PubMedCrossRefGoogle Scholar
  4. 4.
    ARENDT J., ALDHOUS M., WRIGHT J. - Synchronisation of a disturbed sleep-wake cycle in a blind man by melatonin treatment. The Lancet, i, 772–773, 1988.CrossRefGoogle Scholar
  5. 5.
    ARENDT J., BOJKOWSKI C., FRANEY C., WRIGHT J., MARKS V. - Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol.J. Clin. Endocrinol. Metab., 60, 1166–1173, 1985.PubMedCrossRefGoogle Scholar
  6. 6.
    ARENDT J., BORBELY A.A., FRANEY C., WRIGHT J. - The effets of chronic small doses of melatonin given in the late afternoon on fatigue in man: a preliminary study.Neurosc. Lett., 45, 317–321, 1984.CrossRefGoogle Scholar
  7. 7.
    ARMSTRONG S.M. - Melatonin: the internal zeitgeber of mammals? Pineal Res. Reviews, 7, 157–202, 1989.Google Scholar
  8. 8.
    ATTENBURROW M.E.J., DOWLING B.A., SHARPLEY A.L., COWEN P.J. - Case-control study of evening melatonin concentration in primary insomnia.BMJ, 312, 1263–1264, 1996.PubMedCrossRefGoogle Scholar
  9. 9.
    BENES L., CLAUSTRAT B., HORRIERE F., GEOFFRIAU M., KONSIL J., PARROTT K.A., DEGRANDE G., MCQUINN R.L., AYRES J.W. - Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin. J. Pharm. Sci., 86, 1115–1119, 1997.PubMedCrossRefGoogle Scholar
  10. 10.
    BOJKOWSKI C.J., ALDHOUS M.E., ENGLISH J., FRA-NEY C., POULTON A.L., SKENE D.J., ARENDT J. - Suppression of nocturnal plasma melatonin and 6-sulphatoxymelatonin by bright and dim light in man.Horm. Metab. Res., 19,437–440,1987.PubMedCrossRefGoogle Scholar
  11. 11.
    BOUGRINE S., CABON P., IGNAZI G., GEOFFRIAU M., BRUN J., CLAUSTRAT B. - Phase delay of rhythm of 6-sulfa-toxy-melatonin-excretion by bright light improves sleep and performance. In: Y. Touitou, J. Arendt and P. Pévet (eds.). Melatonin and the pineal gland - From basic science to clinical application. Elsevier Science Publishers, 219–223, 1993.Google Scholar
  12. 12.
    BROADWAY J., ARENDT J., FOLKARD S. - Bright light phase shifts the human melatonin rhythm during the Antarctic winter. Neurosc. Lett., 79, 185–189, 1987.CrossRefGoogle Scholar
  13. 13.
    BURESOVA M., DVORAKOVA M., ZVOLSKY P., ILLNEROVA H. - Early morning bright light phase advances the human circadian pacemaker within one day. Neurosc. Lett., 121,47–50, 1991.CrossRefGoogle Scholar
  14. 14.
    CAJOCHEN C., KRAUCHI K., VON ARX M.A., MORI D., GRAW P., WIRZ-JUSTICE A. - Daytime melatonin administration enhances sleepiness and theta/alpha activity in the waking EEG. Neurosc. Lett., 207, 209–213, 1996.CrossRefGoogle Scholar
  15. 15.
    CAMPBELL S.S., DAWSON D. - Enhancement of nighttime alertness and performance with bright ambient light. Physiol. and Behav., 48, 317–320, 1990.CrossRefGoogle Scholar
  16. 16.
    CARMAN J.S., POST R.M., BUSWELL R., GOODWIN F.K. - Negative effects of melatonin on depression. Am. J. Psychiatry, 133, 1181–1186, 1976.PubMedGoogle Scholar
  17. 17.
    CHAZOT G., CLAUSTRAT B., BRUN J., JORDAN D., SASSOLAS G., SCHOTT B. - A chronobiological study of melatonin, cortisol growth hormone and prolactin secretion in cluster headache. Cephalalgia, 4,213–220, 1984.PubMedCrossRefGoogle Scholar
  18. 18.
    CLAUSTRAT B., BRUN J., DAVID M., SASSOLAS G., CHAZOT G. - Melatonin and jet lag: confirmatory result using a simplified protocol. Biol. Psychiatry, 32, 705–711, 1992.PubMedCrossRefGoogle Scholar
  19. 19.
    CLAUSTRAT B., BRUN J., GARRY P., ROUSSEL B., SASSOLAS G. - A once-repeated study of nocturnal plasma melatonin patterns and sleep recordings in six normal young men. J. Pineal Res., 3, 301–310, 1986.PubMedCrossRefGoogle Scholar
  20. 20.
    CLAUSTRAT B., BRUN J., GEOFFRIAU M., ZAIDAN R., MALLO C., CHAZOT G. - Nocturnal plasma melatonin profile and melatonin kinetics during infusion in status migrainosus. Cephalalgia, 17, 511–517, 1997.PubMedCrossRefGoogle Scholar
  21. 21.
    CLAUSTRAT B., LOISY C., BRUN J., BEORCHIA S., ARNAUD J.L., CHAZOT G. - Nocturnal plasma melatonin levels in migraine: a preliminary report. Headache,29, 241 -244, 1989.CrossRefGoogle Scholar
  22. 22.
    CRAMER H., RUDOLPH J., CONSBRUCK V., KENDEL K. - On the effects of melatonin on sleep and behaviour on man. In: Costa E., Costa G., Sandier P. (eds.,), Advances in biochemical psychopharmacology, Raven Press, New York, 11, 187–191, 1974.Google Scholar
  23. 23.
    DAGAN Y., ZISAPEL N., NOF D., LAUDON M., ATSMON J. - Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report Eur. Neuropsychopharmacol., 7, 157–160, 1997.CrossRefGoogle Scholar
  24. 24.
    Dahlitz M., Alvarez B., Vignau J., English J., Arendt J., Parkes J.D. - Delayed sleep phase syndrome response to melatonin. The Lancet, 337, 1121–1124, 1991.CrossRefGoogle Scholar
  25. 25.
    DAWSON D., ENCEL N. - Melatonin and sleep in humans. J. Pineal Res., 15, 1–12, 1993.PubMedCrossRefGoogle Scholar
  26. 26.
    DEACON S., ARENDT J. - Posture influences melatonin concentrations in plasma and saliva in humans. Neurosc. Lett., 167, 191–194, 1994.CrossRefGoogle Scholar
  27. 27.
    DEPREUX P., LESIEUR D., AIT MANSOUR H., MORGAN P., HOWELL H.E., RENARD P., CAIGNARD D.H., PFEIFFER B., DELAGRANGE P., GUARDIOLA B., YOUS S., DEMARQUE A., ADAM G., ANDRIEUX J. - Synthesis and structure-activity relationships of novel naphthalenic and bioisosteric related amidic derivatives as melatonin receptor ligands. J. Med. Chem., 37, 3231–3239, 1994.PubMedCrossRefGoogle Scholar
  28. 28.
    DIJK D.J., ROTH C, LANDOLT H.P., WERTH E., AEP-PLI M., ACHERMANN P., BORBELY A.A. - Melatonin effect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activity. Neurosc. Lett., 201, 13–16, 1995.CrossRefGoogle Scholar
  29. 29.
    EDGAR D.M., DEMENT W.C., FULLER C.A. - Effect of SCN lesions on sleep in squirrel monkeys: evidence for opponent processes in sleep-wake regulation. J. Neurosc., 13, 1065-1079, 1993.Google Scholar
  30. 30.
    ELLIS C.M., LEMMENS G., PARKES J.D. - Melatonin and insomnia. J. Sleep Res.,5, 61–65, 1996.PubMedCrossRefGoogle Scholar
  31. 31.
    FAUTECK J.D., LERCHL A., BERGMANN M., MOLLER M., FRASCHINI F., WITTKOWSKI W., STANKOV B. - The adult human cerebellum is a target of the neuroendocrine system involved in the circadian timing. Neurosc. Lett.,179,60–64,1994.CrossRefGoogle Scholar
  32. 32.
    FOLKARD S., ARENDT J., CLARK M. - Can melatonin improve shift workers’ tolerance of the night shift? Some preliminary findings. Chronobiol. Int., 10, 315–320, 1993.PubMedCrossRefGoogle Scholar
  33. 33.
    FOLLENIUS M., WEIBEL L., BRANDENBERGER G. - Distinct modes of melatonin secretion in normal men. J. Pineal Res., 18, 135–140, 1995.PubMedCrossRefGoogle Scholar
  34. 34.
    GARFINKEL D., LAUDON M., ZISAPEL N. - Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs. Arch. of Gerontology and Geriatrics,24, 223–231, 1997.CrossRefGoogle Scholar
  35. 35.
    HAIMOV I., LAUDON M., ZISAPEL N., SOUROUJON M., NOF D., SHLITNER A., HERER P., TZISCHINSKY O., LA VIE P. - Sleep disorders and melatonin rhythms in elderly people. BMJ, 309, 167, 1994.PubMedCrossRefGoogle Scholar
  36. 36.
    HAJAK G., RODENBECK A., STAEDT J., BANDELOW B., HUETHER G., RUTHER E. - Nocturnal plasma melatonin levels in patients suffering from chronic primary insomnia. J. Pineal Res., 19, 116–122, 1995.PubMedCrossRefGoogle Scholar
  37. 37.
    HORNE J.A., DONLON J., ARENDT J. - Green light attenuates melatonin output and sleepiness during sleep deprivation. Sleep, 14, 233–240, 1991.PubMedGoogle Scholar
  38. 38.
    IGUCHI H., KATO K.I., IBAYASHI H. - Melatonin serum levels and metabolic clearance rate in patients with liver cirrhosis. J. Clin. Endocrinol. Metab., 54, 1025–1027, 1982.PubMedCrossRefGoogle Scholar
  39. 39.
    JAMES S.P., SACK D.A., ROSENTHAL N.E., MENDELSON W.B. - Melatonin administration in insomnia. Neuro-psychopharmacology, 3, 19–23, 1990.Google Scholar
  40. 40.
    JAN J.E., O’DONNELL M.E. - Use of melatonin in the treatment of paediatric sleep disorders. J. Pineal Res., 21, 193–199, 1996.PubMedCrossRefGoogle Scholar
  41. 41.
    KAUPPILA A., KJVELA A., PAKARINEN A., VAKKURJ O. - Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. J. Clin. Endocrinol. Metab., 65,823–828, 1987.PubMedCrossRefGoogle Scholar
  42. 42.
    KLEIN D.C., MOORE R.Y. - Pineal N-acetyltransferase and hydroxyindole-o-methyltrans-ferase: control by the retinohypothalamic tract and the suprachiasmatic nucleus. Brain Res., 174, 245–262, 1979.PubMedCrossRefGoogle Scholar
  43. 43.
    LEE B.J., PARROTT K.A., AYRES J.W., SACK R.L. - Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res. Commun. Mol. Pathol. Pharmacol., 5, 337–346, 1994.Google Scholar
  44. 44.
    LERNER A.B., CASE J.D., TAKAKASHI Y., LEE T.H., MORI W. - Isolation of melatonin, the pineal gland factor that lightens melanocytes. J. Am. Chem. Soc., 80, 2587, 1958.CrossRefGoogle Scholar
  45. 45.
    LEWY A.J., AHMED S., LATHAM JACKSON J.M., SACK R.L. - Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol. Int., 9, 380–392, 1992.PubMedCrossRefGoogle Scholar
  46. 46.
    LEWY A.J., SACK R.L. - The dim light melatonin onset as a marker for circadian phase position. Chronobiol. Int., 6,93–102, 1989.PubMedCrossRefGoogle Scholar
  47. 47.
    LEWY A.J., WEHR T.A., GOODWIN F.K., NEWSOME D.A., MAKEY S.P. - Light suppresses melatonin secretion in humans. Science, 210, 1267–1269, 1980.PubMedCrossRefGoogle Scholar
  48. 48.
    LISSONI P., BARNI S., ROVELLI F., BRIVIO F., ARDIZZOIA A., TANCINI G., CONTI A., MAESTRONI G.J.M. -Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results. Eur. J. Cancer, 29A, 185–189, 1993.PubMedCrossRefGoogle Scholar
  49. 49.
    MALLO C., ZAIDAN R., GALY G., VERMEULEN E., BRUN J., CHAZOT G., CLAUSTRAT B. - Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur. J. Clin. Pharmacol, 38,297–301, 1990.PubMedCrossRefGoogle Scholar
  50. 50.
    MCARTHUR A.J., GILLETTE M.U., PROSSER R.A. - Melatonin directly resets the rat suprachiasmatic circadian clock in vitro. Brain Res., 565, 158–161, 1991.PubMedCrossRefGoogle Scholar
  51. 51.
    MONTELEONE P., ESPOSITO G., LA ROCCA A., MAJ M. - Does bright light suppress nocturnal melatonin secretion more in women than men? J. Neural Transm., 102, 75–80, 1995.CrossRefGoogle Scholar
  52. 52.
    MONTI J.M., ALVARVINO F., CARDINALI D.P., SAVIO I., PINTOS A. - Polysomnographic study of the effect of melatonin on sleep in elderly patients with chronic primary insomnia. Arch, of Gerontology and Geriatrics, 28, 85–98,1999.CrossRefGoogle Scholar
  53. 53.
    MONTI J.M., CARDINALI D.P. - A critical assessment of the melatonin effect on sleep in humans. Biol. Signals Recept., 9, 328–339, 2000.PubMedCrossRefGoogle Scholar
  54. 54.
    MOORE R.Y. - The innervation of the mammalian pineal gland. In: Reiter R.J. (ed.), The pineal and reproduction. Karger, Basel, 1–29, 1978.Google Scholar
  55. 55.
    MORGAN P.J., BARRETT P., HOWELL H.E., HELLIWELL R. - Melatonin receptors: Localization, molecular pharmacology and physiological significance. Neurochem. Int., 24, 101–146, 1994.PubMedCrossRefGoogle Scholar
  56. 56.
    NAVE R., HERER P., HAIMOV I., SHLITNER A., LA VIE P. - Hypnotic and hypothermic effects of melatonin on daytime sleep in humans: lack of antagonism by flumazenil. Neurosc. Lett., 214, 123–126, 1996.CrossRefGoogle Scholar
  57. 57.
    NORDLUND J.J., LERNER A.B. - The effect of oral melatonin on skin color and on the release of pituitary hormones. J. Clin. Endocrinol. Metab., 45, 768–774, 1977.PubMedCrossRefGoogle Scholar
  58. 58.
    O’BRIEN I.A.D., LEWIN I.G., O’HARE J.P., ARENDT J., CORRAL RJ.M. - Abnormal circadian rhythm of melatonin in diabetic autonomic neuropathy. Clin. Endocrinol., 24, 359–364, 1986.CrossRefGoogle Scholar
  59. 59.
    Pardridge W.M., Mietus L.J. - Transport of albumin-bound melatonin through the blood-brain barrier. J. Neurochem., 34, 1761–1763, 1980.PubMedCrossRefGoogle Scholar
  60. 60.
    PETRIE K., CONAGLEN J.V., THOMPSON L., CHAMBERLAIN K. - Effect of melatonin on jet lag after long haul flights. BMJ, 298, 705–707, 1989.PubMedCrossRefGoogle Scholar
  61. 61.
    REITER R.J., MELCHIORRI D., SEWERYNEK E., POEGGELER B., BARLOW-WALDEN L., CHUANG J., ORTIZ G.G., ACUNA-CASTROVIEJO D. - A review of the evidence supporting melatonin’s role as an antioxidant. J. Pineal Res., 18, 1–11, 1995.PubMedCrossRefGoogle Scholar
  62. 62.
    REPPERS S.M., WEAVER D.R., RIVKEES S.A., STOPA E.G. - Putative melatonin receptors in a human biological clock. Science, 242, 78–91, 1988.CrossRefGoogle Scholar
  63. 63.
    SHANAHAN T.L., CZEISLER C.A. - Light exposure induces equivalent phase shifts of the endogenous circadian rhythms of circulating plasma melatonin and core body temperature in men. J. Clin. Endocrinol. Metab., 73, 227–235, 1991.PubMedCrossRefGoogle Scholar
  64. 64.
    SHIBATA S., CASSONE V.M., MOORE R.Y. - Effects of melatonin on neuronal activity in the rat suprachiasmatic nucleus in vitro. Neurosc. Lett., 97, 140–144, 1989.CrossRefGoogle Scholar
  65. 65.
    SIEGRIST C., BENEDETTI C., ORLANDO A., BELTRAM J.M., TUCHSCHERR L., NOSEDA C.M.J., BRUSCO L.I., CARDINALI D.P. - Lack of changes in serum prolactin, FSH, TSH, and estradiol after melatonin treatment in doses that improve sleep and reduce benzodiazepine consumption in sleep-disturbed, middle-aged and elderly patients. J. Pineal Res., 30, 34–42, 2001PubMedCrossRefGoogle Scholar
  66. 66.
    Strassmann R.J., Qualls C.R., Lisansky E.J., Peake G.T. - Elevated rectal temperature produced by all-night bright light is reversed by melatonin infusion in men. J. Appl. Physiol., 71, 2178–2182, 1991.Google Scholar
  67. 67.
    Suhner A., Schlagenhauf P., Johnson R., Tschopp A., Steffen R. - Comparative study to determine the optimal melatonin dosage form for the alleviation of Jet lag. Chronol. Int. 15, 655–666, 1998.CrossRefGoogle Scholar
  68. 68.
    Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., Reiter R.J. - Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr. J., 1, 57–60, 1993.Google Scholar
  69. 69.
    Tan, D.X., Poeggeler B., Reiter R.J., Chen L.D., Manchester L.C., Barlow-Walden L.R. - The pineal hormone melatonin inhibits DNA adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett., 70,65–71,1993.PubMedCrossRefGoogle Scholar
  70. 70.
    Touitou Y., Fevre M., Bogdan A., Reemberg A., De Prins J., Beck H., Touitou C. - Patterns of plasma melatonin with ageing and mental condition: stability of nyctohemeral rhythms and differences in seasonal variations. Ada Endocr., 106, 145–151, 1984.PubMedGoogle Scholar
  71. 71.
    Touitou Y., Fevre M., Lagoguey M., Carayon A., Bogdan A., ReinbergA., Beck H., Cesselin F., Touitou C. - Age and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man. J. Endocr., 91,467–475, 1981.PubMedCrossRefGoogle Scholar
  72. 72.
    Trinchard-Lugan I., Waldhauser F. - The short term secretion pattern of human serum melatonin indicates apulsatile hormone release. J. Clin. Endocrinol. Metab., 69, 663–669, 1989.PubMedCrossRefGoogle Scholar
  73. 73.
    Tzischinsky O., Lavie P. - Melatonin possesses time-dependent hypnotic effects. Sleep, 17, 638–645, 1994.PubMedGoogle Scholar
  74. 74.
    Vakkuri O. - Diurnal rhythm of melatonin in human saliva. Acta. Physiol. Scan., 124, 409–412, 1985.CrossRefGoogle Scholar
  75. 75.
    Voordouw B.C.G., Euser R., Verdonk R.E.R., Alberda B.T.H., De Jong F.H., DrogendIJk A.A.T.C., Fauser B.C.J.M., Cohen M. - Melatonin and Melatonin-Progestin combination alter pituitary-ovarian function in women can inhibit ovulation. J. Clin. Endocrinol. Metab., 74, 108–117, 1992.PubMedCrossRefGoogle Scholar
  76. 76.
    Waldenlind E., Gustafsson S., Ekbom K., Wetterberg L. - Circadian secretion of cortisol and melatonin in cluster headache during active cluster periods and remission. J. Neurol. Neurosurg. Psychiatry, 50, 207–213, 1987.PubMedCrossRefGoogle Scholar
  77. 77.
    Waldhauser F., Vierhapper H., Pirich K. - Abnormal circadian melatonin secretion in night shift workers. New Engl.J.Med., 315, 1614–1615, 1986.PubMedGoogle Scholar
  78. 78.
    Wehr T.A. - The durations of human melatonin secretion and sleep respond to changes in daylength (photope-riod). J. Clin. Endocrinol. Metab., 73, 1276–1280, 1991.PubMedCrossRefGoogle Scholar
  79. 79.
    Wirz-Justice A., Armstrong S.M. - Melatonin: nature’s soporific? J. Sleep Res., 5, 137–141, 1996.PubMedGoogle Scholar
  80. 80.
    Zaidan R., Geoffriau M., Brun J., Taillard J., Bureau C., Chazot G., Claustrat B. - Melatonin is able to influence its secretion in humans: description of a phase-response curve. Neuroendocrinology, 60, 105–112, 1994.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • B. Claustrat
    • 1
  1. 1.Service de Radiopharmacie et de Radioanalyse, Centre de Médecine NucléaireHôpital Neuro-CardiologiqueLyonFrance

Personalised recommendations